Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L

Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347

Authors: FOWLER JS VOLKOW ND LOGAN J WANG GJ WOLF A SCHLYER D MACGREGOR R PAPPAS N SHEA C ALEXOFF D GATLEY SJ DORFLINGER E MORAWSKY L YOO K FAZINNI E

Citation: Js. Fowler et al., PET STUDIES OF REVERSIBLE AND IRREVERSIBLE MAO-B INHIBITORS, The Journal of nuclear medicine, 34(5), 1993, pp. 131-132

Authors: FOWLER JS VOLKOW ND LOGAN J SCHLYER DJ MACGREGOR RR WANG GJ WOLF AP PAPPAS N ALEXOFF D SHEA C GATLEY SJ DORFLINGER E YOO K MORAWSKY L FAZZINI E

Citation: Js. Fowler et al., MONOAMINE OXIDASE-B (MAO-B) INHIBITOR THERAPY IN PARKINSONS-DISEASE -THE DEGREE AND REVERSIBILITY OF HUMAN BRAIN MAO-B INHIBITION BY RO 196327, Neurology, 43(10), 1993, pp. 1984-1992